{"id":1828,"date":"2005-11-01T12:03:00","date_gmt":"2005-11-01T11:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/sequenzielle-behandlung-der-osteoporose-mit-parathormon-und-alendronat"},"modified":"2022-03-17T14:10:53","modified_gmt":"2022-03-17T13:10:53","slug":"sequenzielle-behandlung-der-osteoporose-mit-parathormon-und-alendronat","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2005\/sequenzielle-behandlung-der-osteoporose-mit-parathormon-und-alendronat","title":{"rendered":"Sequenzielle Behandlung der Osteoporose mit Parathormon und Alendronat"},"content":{"rendered":"<p>Wir haben erste klinische Ergebnisse zur Wirksamkeit von t\u00e4glich sc. injiziertem Parathormon (PTH) bei postmenopausaler Osteoporose referiert (1, 2). Vom PTH erhofft man sich eine g\u00fcnstige Wirkung bei Osteoporose, da es &#8211; in pulsatiler Form zugef\u00fchrt &#8211; in den ersten Wochen die Osteoblasten, d.h. die Knochenneubildung, stimuliert. Allerdings wird in einer sp\u00e4teren Phase durch PTH [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wir haben erste klinische Ergebnisse zur Wirksamkeit von t\u00e4glich sc. injiziertem Parathormon (PTH) bei postmenopausaler Osteoporose referiert (1, 2). Vom PTH erhofft man sich eine g\u00fcnstige Wirkung bei Osteoporose, da es &#8211; in pulsatiler Form zugef\u00fchrt &#8211; in den ersten Wochen die Osteoblasten, d.h. die Knochenneubildung, stimuliert. Allerdings wird in einer sp\u00e4teren Phase durch PTH [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[386,3611,3610,70,551,4036],"class_list":["post-1828","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-alendronat","tag-knochen-mineralgehalt","tag-knochendichte","tag-osteoporose","tag-parathormon","tag-path-studie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1828"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1828\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}